GRAIL Reports Third Quarter 2026 Financial Results

The Quick Take
FDA Advisory Committee Voted in Favor of Approval of GRAIL's Galleri Multi-Cancer Early Detection Test Q3 Galleri®Test Volume Increased ~24% to More Than 56,000 Year-Over-Year, Year-to-Date Test Volume Increased ~36% to More Than 174,000 Q3 Galleri Revenue Grew 14% Year-Over-Year to $37.3...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.
Related
Business
BROCO ENERGY AWARDED TWO FIVE-YEAR MASSACHUSETTS STATEWIDE FUEL CONTRACTS
Statewide awards include renewable diesel, biodiesel, heating oil and eligible liquid biofuel for public entities across the Commonwealth. BOSTON, Nov. 4, 2026…
Business
Goldcom earnings missed by $0.88, revenue fell short of estimates
Business
Olin extends receivables purchase agreement termination date to July 2028
Business
